Stocks: 503 Market Cap: $51.2T S&P 500: 5,954.50 +0.82%
500 500Market
Biogen
BIIB Rank #331 Health Care
$187.24 -2.39%

Key Statistics

Market Cap
$27.48B
Volume (24h)
$332.4M
P/E Ratio
21.3
EPS
$8.79
1 Day
-2.39%
7 Day
-2.49%
YTD
-4.99%
Sector
Health Care
S&P 500 Rank
#331
52W Low: $162.92 52W High: $219.05

About Biogen

Biogen is a biotechnology company that develops, manufactures, and commercializes therapies for the treatment of neurological and autoimmune diseases. The company's key products include multiple sclerosis treatments such as Avonex, Tysabri, and Plegridy, as well as spinal muscular atrophy treatment Spinraza and Alzheimer's disease treatment Aduhelm. Biogen's innovative therapies have improved the lives of millions of patients worldwide, making it a leader in the healthcare industry.

Latest News

Loading latest news...

Sector Peers — Health Care

LLY — Lilly (Eli) $1,027.59 -2.32% JNJ — Johnson & Johnson $247.67 -0.31% ABBV — AbbVie $233.22 +0.49% MRK — Merck & Co. $121.20 -2.11% UNH — UnitedHealth Group $290.56 -0.92% AMGN — Amgen $384.71 -0.89% ABT — Abbott Laboratories $114.46 -1.62% TMO — Thermo Fisher Scientific $506.43 -2.82% View all Health Care stocks →

Daily Market Brief

S&P 500 closing prices, top movers, and sector performance — delivered daily.